Grange J D, Gouyette A, Gutmann L, Amiot X, Kitzis M D, Islam S, Acar J F, Jaillon P
Service d'hépatologie et unité de Pharmacologie Clinique, Hôpital Tenon, Paris, France.
J Antimicrob Chemother. 1989 Apr;23(4):605-11. doi: 10.1093/jac/23.4.605.
A combination of amoxycillin and clavulanic acid (Augmentin) might be useful for first-line treatment of spontaneous bacterial peritonitis in patients with cirrhosis. We have studied the pharmacokinetics of amoxycillin/clavulanic acid in serum and ascitic fluid of six cirrhotic patients. A total of 66 simultaneous serum and ascitic samples were analysed. Following iv injection of 1 g amoxycillin plus 0.2 g clavulanic acid, the ascites to serum AUC ratio was 1.38 for amoxycillin and 1.01 for clavulanic acid, indicating a good distribution of these drugs into the ascitic fluid. In this study, experimental data were fitted to a three compartment body model which revealed that the prolonged serum half-lives of amoxycillin (274 min) and clavulanic acid (200 min) were probably due to the slow return from the ascitic compartment.